Drug Type Small molecule drug |
Synonyms MRS 2211, MRS2211 |
Target |
Mechanism P2Y13 receptor inhibitors(P2Y purinoceptor 13 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H12ClN4O8P |
InChIKeyKVBPUONUZZVJFQ-UHFFFAOYSA-N |
CAS Registry219554-11-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Astrocytoma | Preclinical | KR | 15 Jul 2005 |